greeksoup/ stock research

HCA Healthcare (HCA) FY2025 results: revenue $75.6 billion, up 7.1% on the year

HCA Healthcare, Inc. (HCA) reported revenue of $75.6 billion for fiscal 2025, the year ended 31 December 2025, up 7.1% on the year before. Net income was $6.8 billion, up 17.8%, and diluted earnings per share $28.33. The figures are the company's own, from the 10-K it filed with the SEC on 10 February 2026.

Revenue
$75.6 billion
+7.1% on the year
FY2018FY2025
Operating margin
13.0%
12.1% a year earlier
FY2018FY2025
Net income
$6.8 billion
+17.8% on the year
FY2018FY2025
Diluted EPS
$28.33
+28.8% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The year in brief

From this 10-K

HCA Healthcare owns and operates hospitals and other care facilities. At 31 December 2025 it ran 190 hospitals, made up of 179 general acute care hospitals, seven behavioral hospitals and four rehabilitation hospitals, along with 121 freestanding ambulatory surgery centres and 31 freestanding endoscopy centres. The facilities sit in 19 states and England. The company commenced operations in 1968 through its predecessors, was incorporated in Delaware in October 2010 and is based in Nashville, Tennessee.

HCA Healthcare, Inc., the 10-K for 2025

HCA Healthcare owns and operates hospitals and other care facilities. At 31 December 2025 it ran 190 hospitals, made up of 179 general acute care hospitals, seven behavioral hospitals and four rehabilitation hospitals, along with 121 freestanding ambulatory surgery centres and 31 freestanding endoscopy centres. The facilities sit in 19 states and England. The company commenced operations in 1968 through its predecessors, was incorporated in Delaware in October 2010 and is based in Nashville, Tennessee.

The hospitals

The 179 general acute care hospitals had 50,436 licensed beds at 31 December 2025. They provide medical and surgical services including inpatient care, intensive care, cardiac care, diagnostic services and emergency services, and outpatient services including outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy. They cover specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. Each hospital has an organised medical staff and a local board of trustees or governing board drawn from the community. The seven behavioral hospitals had 714 licensed beds and provide child, adolescent and adult psychiatric care and alcohol and drug abuse treatment and counselling.

Care outside the hospital

Outpatient and ancillary services are delivered through the acute care hospitals themselves and through ambulatory surgery centres, freestanding emergency care facilities, urgent care facilities, walk-in clinics, physician practices, diagnostic centres, home health agencies, hospices and rehabilitation facilities.

Who pays

Payment for patient services comes from the federal government through Medicare, from state governments through Medicaid and similar programmes, from managed care plans including those offered through federal and state health insurance marketplaces, from private insurers and directly from patients. By share of revenues in 2025, managed care and other insurers were 48.9%, managed Medicare 17.8%, Medicare 14.9%, Medicaid 7.8%, managed Medicaid 4.9%, international managed care and other insurers 2.5% and other, including uninsured patients, 3.2%. Medicare covers people aged 65 and over, some disabled people and people with end-stage renal disease or amyotrophic lateral sclerosis; Medicaid is a federal-state programme run by the states for qualifying low-income individuals. All of the company's general acute care hospitals in the United States are enrolled in both. The filing notes that amounts received under Medicare and Medicaid are generally much less than established hospital gross charges for the same services.

Strategy

The stated aim is to be the health care system of choice in the communities served by building comprehensive local networks and supporting them with enterprise expertise and scale. The growth agenda includes growing in existing markets, improving clinical, operational and satisfaction measures, attracting physicians and other health care professionals, developing more services, widening access and coordinating care across the network.

People

The workforce was approximately 320,000 employees at 31 December 2025, including approximately 90,000 part-time and as-needed employees. Human capital matters are overseen by the board and its committees through regular reporting from management and advisers.

From HCA Healthcare's annual report on Form 10-K for the year ended 31 December 2025. The filing

Written from the 10-K filed 10 February 2026: read the full 10-K.

The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025

Income statement (profit and loss)

$ millionFY2025FY2024FY2023On the yearLast 8 years
Revenue75,60070,60364,968+7.1%
Operating income9,8328,5237,706+15.4%
Operating margin13.0%12.1%11.9%
Interest expense2,2482,0611,938+9.1%
Pre-tax income9,8328,5237,706+15.4%
Income tax2,0501,8661,615+9.9%
Effective tax rate20.9%21.9%21.0%
Net income6,7845,7605,242+17.8%
Net margin9.0%8.2%8.1%
Diluted EPS$28.33$22.00$18.97+28.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2025FY2024FY2023On the yearLast 8 years
Operating cash flow12,63610,5149,431+20.2%
Capital expenditure4,9444,8754,744+1.4%
Free cash flow7,6925,6394,687+36.4%
Free cash flow margin10.2%8.0%7.2%
Cash from investing-4,988-4,933-5,317
Cash from financing-8,550-4,582-4,094
Depreciation and amortisation3,5233,3123,077+6.4%
Share-based compensation401360262+11.4%
Buybacks10,0676,0423,811+66.6%
Dividends paid679690661-1.6%
Dividend per share$2.88$2.64$2.40+9.1%
Diluted shares, weighted239m262m276m-8.5%
Shares outstanding at period end225m250m266m-10.2%

Balance sheet

$ millionFY2025FY2024FY2023On the yearLast 8 years
Shareholders' equity-6,027-2,499-1,774
Non-controlling interest3,2563,0542,834+6.6%
Debt46,49243,03139,593+8.0%
Operating lease liabilities1,8531,8631,903-0.5%
Finance lease liabilities625624541+0.2%
Other liabilities14,52113,44013,114+8.0%
Total liabilities and equity60,72059,51356,211+2.0%
Fixed assets31,14129,41427,715+5.9%
Investments485569477-14.8%
Cash and equivalents1,0401,933935-46.2%
Receivables10,86710,7519,958+1.1%
Inventory1,6521,7382,021-4.9%
Other assets15,53515,10815,105+2.8%
Total assets60,72059,51356,211+2.0%

10-K for the year ended 31 December 2025, filed 10 February 2026: the filing.